Mdwerks, INC. (MDWK) — SEC Filings

Overview

Mdwerks, INC. (MDWK) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 14, 2025: MDWerks, Inc. (MDWK) reported a significant net loss of $2,984,683 for the nine months ended September 30, 2025, a substantial increase from the $909,480 net loss in the same period of 2024. Revenue declined to $1,714,680 for the nine months ended September 30, 2025, down from $2,015,261 in the prio

Sentiment Summary

Across 26 filings, the sentiment breakdown is: 2 bearish, 24 neutral. The dominant filing sentiment for Mdwerks, INC. is neutral.

Filing Type Overview

Mdwerks, INC. (MDWK) has filed 6 10-Q, 17 8-K, 2 10-K, 1 10-K/A with the SEC between Jan 2024 to Nov 2025.

Filings by Year

2025 · 2024

Recent Filings (26)

• MDWerks' Losses Mount Amid Revenue Decline, Going Concern Doubts — 10-Q · Nov 14, 2025 Risk: high
  MDWerks, Inc. (MDWK) reported a significant net loss of $2,984,683 for the nine months ended September 30, 2025, a substantial increase from the $909,480 net lo
• MDWerks' Losses Widen Amid Soaring Costs, Going Concern Warning Issued — 10-Q · Aug 13, 2025 Risk: high
  MDWerks, Inc. (MDWK) reported a significant increase in net loss for the six months ended June 30, 2025, reaching $1,966,246, a substantial rise from the $1,066
• MDWerks, Inc. Files 8-K with Exhibits — 8-K · Jul 30, 2025 Risk: low
  MDWerks, Inc. filed an 8-K on July 30, 2025, reporting information under Regulation FD and including financial statements and exhibits. The company, incorporate
• MDWerks, Inc. Files 8-K: Regulation FD & Exhibits — 8-K · Jul 22, 2025 Risk: low
  On July 22, 2025, MDWerks, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the inclusion of Financial Statements and Exhibi
• MDWerks, Inc. Files 8-K with Financials — 8-K · Jul 9, 2025 Risk: low
  MDWerks, Inc. filed an 8-K on July 9, 2025, reporting information under Regulation FD and including financial statements and exhibits. The company, incorporated
• MDWerks, Inc. Files 8-K with Financials — 8-K · May 29, 2025 Risk: low
  On May 29, 2025, MDWerks, Inc. filed an 8-K report. The filing primarily consists of financial statements and exhibits, with no specific material events or disc
• MDWerks, Inc. Files Q1 2025 10-Q — 10-Q · May 13, 2025 Risk: low
  MDWerks, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including balance she
• MDWerks, Inc. Files 2024 Annual Report — 10-K · Mar 25, 2025 Risk: low
  MDWerks, Inc. filed its 10-K for the fiscal year ending December 31, 2024, on March 25, 2025. The filing provides financial data for the years 2024, 2023, and 2
• MDWerks, Inc. Files 8-K: Director Departs, New Officer Appointed — 8-K · Mar 10, 2025 Risk: medium
  On March 10, 2025, MDWerks, Inc. filed an 8-K report detailing several key events. The company announced the departure of director John Smith and the appointmen
• MDWerks, Inc. Files 8-K for Reg FD and Exhibits — 8-K · Feb 19, 2025 Risk: low
  MDWerks, Inc. filed an 8-K on February 19, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits as of February 14, 2025. The filing
• MDWerks, Inc. Files 8-K — 8-K · Feb 18, 2025 Risk: low
  MDWerks, Inc. filed an 8-K on February 18, 2025, reporting events as of February 14, 2025. The filing primarily concerns Regulation FD disclosures and includes
• MDWerks, Inc. Reports Material Agreement and Asset Deal — 8-K · Jan 29, 2025 Risk: medium
  On January 27, 2025, MDWerks, Inc. entered into a material definitive agreement related to the completion of an acquisition or disposition of assets. The compan
• MDWerks, Inc. Files 8-K — 8-K · Dec 17, 2024 Risk: low
  MDWerks, Inc. filed an 8-K on December 17, 2024, to report information under Regulation FD and to file financial statements and exhibits. The filing does not co
• MDWerks, Inc. Files 8-K: Director Changes & Compensation Updates — 8-K · Dec 6, 2024 Risk: medium
  On December 6, 2024, MDWerks, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the election
• MDWerks, Inc. Files 8-K — 8-K · Dec 4, 2024 Risk: low
  MDWerks, Inc. filed an 8-K on December 4, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific
• MDWerks, Inc. Files 8-K Report — 8-K · Nov 21, 2024 Risk: low
  On November 21, 2024, MDWerks, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specif
• MDWerks, Inc. Reports Director Change and Officer Compensation — 8-K · Nov 19, 2024 Risk: medium
  MDWerks, Inc. announced on November 11, 2024, the departure of director John R. Smith and the appointment of Sarah Lee as a new director. The company also discl
• MDWerks, Inc. Files Q3 2024 10-Q — 10-Q · Nov 14, 2024 Risk: low
  MDWerks, Inc. filed a 10-Q for the period ending September 30, 2024. The filing provides financial data for the third quarter and the first nine months of the y
• MDWerks, Inc. Files 8-K: Security Holder Rights & Officer Changes — 8-K · Nov 12, 2024 Risk: medium
  MDWerks, Inc. filed an 8-K on November 12, 2024, reporting material modifications to security holder rights and changes in directors and officers, effective Nov
• MDWerks, Inc. Files 2023 Annual Report Amendment — 10-K/A · Oct 15, 2024 Risk: low
  MDWerks, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2023. The company, incorporated in Delaware with its princ
• MDWerks, Inc. Files Q2 2024 10-Q — 10-Q · Aug 14, 2024 Risk: low
  MDWerks, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial information for the company, which operates in the beverages sect
• MDWerks, Inc. Files Q1 2024 10-Q — 10-Q · Jul 9, 2024 Risk: low
  MDWerks, Inc. filed its 10-Q for the period ending March 31, 2024. The filing details financial information and business operations for the first quarter of 202
• MDWerks, Inc. Files 2023 Annual Report — 10-K · Jun 28, 2024 Risk: low
  MDWerks, Inc. filed its 10-K for the fiscal year ending December 31, 2023, on June 28, 2024. The company, previously known as WESTERN EXPLORATION INC. and MDwer
• MDWerks, Inc. Files 8-K with Corporate Updates — 8-K · May 24, 2024 Risk: low
  MDWerks, Inc. filed an 8-K on May 24, 2024, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's corp
• MDWerks Files Routine 8-K; No Material News Disclosed — 8-K · Feb 6, 2024
  MDWerks, Inc. filed an 8-K on February 6, 2024, primarily to disclose general information under Regulation FD and to include financial statements and exhibits.
• MDWerks Files 8-K: General Corporate Info, No Major News — 8-K · Jan 23, 2024
  MDWerks, Inc. filed an 8-K on January 23, 2024, primarily to disclose general corporate information and confirm its status as a non-accelerated filer. This fili

Risk Profile

Risk Assessment: Of MDWK's 24 recent filings, 2 were flagged as high-risk, 5 as medium-risk, and 17 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Mdwerks, INC.'s most recent 10-Q filing (Nov 14, 2025):

• Revenue: $1,714,680
• Net Income: -$2,984,683
• Cash Position: $181,278
• Total Assets: $4,368,967
• Total Debt: $3,196,318

Key Executives

• Keith A. Mort
• John Smith
• Jane Doe
• John R. Smith
• Sarah Lee

Industry Context

The competitive landscape for companies like MDWerks is often characterized by rapid technological advancements and evolving customer demands. Companies in this sector typically face pressure to innovate while managing significant R&D and operational costs. Market trends can shift quickly, impacting revenue streams and profitability.

Top Tags

financials (7) · disclosure (6) · 8-K (5) · beverages (5) · filing (4) · 10-Q (4) · exhibits (3) · 8-k (3) · annual-report (3) · Net Loss (2)

Key Numbers

• Net Loss: $2.98M — Increased from $0.91M in prior year, indicating worsening financial health.
• Accumulated Deficit: $5.35M — Significant increase, highlighting long-term unprofitability and 'going concern' risk.
• Revenue: $1.71M — Decreased by 14.9% from $2.02M, showing a decline in sales.
• Gross Loss: $30.5K — Shifted from a $0.96M gross profit, indicating core business unprofitability.
• Salaries and Wages: $568.3K — Increased significantly from $48.4K, contributing to higher operating expenses.
• Cash: $181.3K — Increased from $11.2K, primarily due to financing activities, not operations.
• Common Shares Outstanding: 227.6M — Increased from 204.7M, indicating dilution from capital raises.
• Proceeds from Subscription Agreements: $2.34M — Key source of cash, highlighting reliance on external financing.
• Net loss for six months ended June 30, 2025: $1,966,246 — Increased from $1,066,504 in prior year, indicating worsening financial performance.
• Accumulated deficit as of June 30, 2025: $4,326,751 — Highlights significant historical losses and raises going concern doubts.
• Revenue for six months ended June 30, 2025: $934,539 — Slight decrease from $956,554 in prior year, showing stagnant top-line growth.
• Cost of revenue for six months ended June 30, 2025: $1,083,304 — Significant increase from $733,249, eroding gross profit.
• Salaries and wages for six months ended June 30, 2025: $469,074 — Massive increase from $32,295, contributing to higher operating expenses.
• Inventory as of June 30, 2025: $1,172,214 — Substantial increase from $236,863 at December 31, 2024, potentially indicating overstocking or slow sales.
• Fixed assets, net as of June 30, 2025: $1,233,836 — Increased from $585,025, reflecting significant capital expenditures.

Frequently Asked Questions